A Rash Diagnosis

    Alana Christensen, Anushia Ashokan, David Gordon
    TLDR The man's rash, hair loss, and vision issues were due to syphilis, not CMV.
    A 46-year-old man presented with a persistent rash, hair loss, and visual impairment initially misdiagnosed as acute cytomegalovirus (CMV) infection based on serology results. Further investigation revealed the correct diagnosis of syphilis, supported by positive Treponema pallidum particle agglutination (TPPA) and reactive rapid plasma reagin (RPR) tests. The patient was treated with intravenous benzylpenicillin and prednisolone, leading to significant improvement in symptoms. This case highlighted the importance of cautious interpretation of positive IgM serology results, which can often be false positives, and the necessity of confirming diagnoses with follow-up testing to demonstrate IgG seroconversion.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 month ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Hair loss products whilst trying to conceive

      in Minoxidil  1 upvotes 1 month ago
      The conversation is about the safety of using hair loss products like Minoxidil and finasteride while trying to conceive and after birth. The user is seeking advice on whether these products are safe for the baby and if any men in similar situations can share their experiences.

      community Hair loss treatment tier list by Dr Oscar Muñoz

      in Treatment  912 upvotes 1 month ago
      Dr. Oscar Muñoz's hair loss treatment tier list suggests oral minoxidil and finasteride are highly effective, while topical treatments like RU58841 and microneedling are less effective. Users discuss the effectiveness of various treatments, with some favoring oral options for their practicality and higher response rates.